Protein Flexibility and Dissociation Pathway Differentiation Can Explain Onset of Resistance Mutations in Kinases.


Journal

Angewandte Chemie (International ed. in English)
ISSN: 1521-3773
Titre abrégé: Angew Chem Int Ed Engl
Pays: Germany
ID NLM: 0370543

Informations de publication

Date de publication:
11 07 2022
Historique:
received: 19 01 2022
pubmed: 30 4 2022
medline: 7 7 2022
entrez: 29 4 2022
Statut: ppublish

Résumé

Understanding how mutations render a drug ineffective is a problem of immense relevance. Often the mechanism through which mutations cause drug resistance can be explained purely through thermodynamics. However, the more perplexing situation is when two proteins have the same drug binding affinities but different residence times. In this work, we demonstrate how all-atom molecular dynamics simulations using recent developments grounded in statistical mechanics can provide a detailed mechanistic rationale for such variances. We discover dissociation mechanisms for the anti-cancer drug Imatinib (Gleevec) against wild-type and the N368S mutant of Abl kinase. We show how this point mutation triggers far-reaching changes in the protein's flexibility and leads to a different, much faster, drug dissociation pathway. We believe that this work marks an efficient and scalable approach to obtain mechanistic insight into resistance mutations in biomolecular receptors that are hard to explain using a structural perspective.

Identifiants

pubmed: 35486370
doi: 10.1002/anie.202200983
pmc: PMC9256798
mid: NIHMS1803513
doi:

Substances chimiques

Benzamides 0
Piperazines 0
Protein Kinase Inhibitors 0
Pyrimidines 0
Imatinib Mesylate 8A1O1M485B
Fusion Proteins, bcr-abl EC 2.7.10.2

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e202200983

Subventions

Organisme : NIGMS NIH HHS
ID : R35 GM119437
Pays : United States
Organisme : NIH HHS
ID : S10 OD028478
Pays : United States

Informations de copyright

© 2022 Wiley-VCH GmbH.

Références

Acta Crystallogr D Biol Crystallogr. 2007 Jan;63(Pt 1):80-93
pubmed: 17164530
Cancer Res. 2004 Sep 15;64(18):6652-9
pubmed: 15374980
J Chem Phys. 2004 Jun 22;120(24):11919-29
pubmed: 15268227
Nature. 1993 Jun 17;363(6430):595-602
pubmed: 8510751
Chembiochem. 2013 Sep 23;14(14):1799-806
pubmed: 23843149
Elife. 2018 Jun 14;7:
pubmed: 29901437
J Am Chem Soc. 2016 Apr 6;138(13):4608-15
pubmed: 26954686
J Chem Theory Comput. 2018 May 8;14(5):2721-2732
pubmed: 29474075
Science. 2000 Sep 15;289(5486):1938-42
pubmed: 10988075
Proc Natl Acad Sci U S A. 2016 Aug 16;113(33):9193-8
pubmed: 27482115
Nat Rev Drug Discov. 2006 Sep;5(9):730-9
pubmed: 16888652
Science. 2002 Dec 6;298(5600):1912-34
pubmed: 12471243
Clin Lymphoma Myeloma Leuk. 2013 Oct;13(5):515-29
pubmed: 23890944
J Phys Chem B. 2021 Jun 10;125(22):5706-5715
pubmed: 33930271
J Am Chem Soc. 2011 Jun 22;133(24):9181-3
pubmed: 21545110
N Engl J Med. 2006 Dec 7;355(23):2408-17
pubmed: 17151364
J Am Chem Soc. 2017 Apr 5;139(13):4780-4788
pubmed: 28290199
Proc Natl Acad Sci U S A. 2010 Oct 12;107(41):17586-91
pubmed: 20921368
Biochim Biophys Acta Gen Subj. 2020 Apr;1864(4):129508
pubmed: 31884066
J Phys Chem Lett. 2018 Sep 6;9(17):4941-4948
pubmed: 30070844
Acc Chem Res. 2003 Jun;36(6):462-9
pubmed: 12809533
Leuk Res. 2014 Jan;38(1):10-20
pubmed: 24131888
Sci Adv. 2017 May 31;3(5):e1700014
pubmed: 28580424
Annu Rev Biophys. 2020 May 6;49:69-85
pubmed: 32375019
Front Mol Biosci. 2019 May 24;6:36
pubmed: 31179286
Curr Opin Chem Biol. 2010 Aug;14(4):467-74
pubmed: 20663707
Science. 2020 Oct 9;370(6513):
pubmed: 33004676
J Phys Chem B. 2019 May 2;123(17):3672-3678
pubmed: 30974941
J Chem Phys. 2020 Sep 28;153(12):125102
pubmed: 33003755
Nat Struct Mol Biol. 2014 Oct;21(10):848-53
pubmed: 25218445
Expert Opin Investig Drugs. 2011 Feb;20(2):153-208
pubmed: 21235428
J Chem Theory Comput. 2014 Apr 8;10(4):1420-5
pubmed: 26580360
Proc Natl Acad Sci U S A. 2020 Aug 11;117(32):19221-19227
pubmed: 32719139
J Phys Chem B. 2015 Jan 29;119(4):1443-56
pubmed: 25548962
Sci Rep. 2019 Feb 20;9(1):2412
pubmed: 30787317
Annu Rep Comput Chem. 2017;13:231-278
pubmed: 29720925
Pharmacol Res. 2015 Oct;100:1-23
pubmed: 26207888
Nat Commun. 2014 Mar 03;5:3397
pubmed: 24584478
J Chem Theory Comput. 2020 Aug 11;16(8):4757-4775
pubmed: 32559068
Structure. 2007 Mar;15(3):299-311
pubmed: 17355866
Br J Pharmacol. 2012 Jul;166(6):1846-59
pubmed: 22324512
Nature. 1997 Feb 13;385(6617):602-9
pubmed: 9024658
Proc Natl Acad Sci U S A. 2013 Jun 25;110(26):10616-21
pubmed: 23754386
Proc Natl Acad Sci U S A. 2019 Apr 2;116(14):6818-6827
pubmed: 30867294
Angew Chem Int Ed Engl. 2006 Jan 30;45(6):993-7
pubmed: 16374788
Elife. 2017 Apr 26;6:
pubmed: 28445123
Cancer Res. 2002 Aug 1;62(15):4236-43
pubmed: 12154025
Nat Struct Mol Biol. 2017 Nov;24(11):893-901
pubmed: 28945248
Science. 2015 Feb 20;347(6224):882-6
pubmed: 25700521
J Biol Chem. 2008 Jun 27;283(26):18292-302
pubmed: 18434310
Nature. 1997 Feb 13;385(6617):595-602
pubmed: 9024657
J Chem Phys. 2017 Oct 21;147(15):152701
pubmed: 29055314
J Chem Theory Comput. 2021 Nov 9;17(11):7260-7270
pubmed: 34647743
Proc Natl Acad Sci U S A. 2015 Feb 3;112(5):E386-91
pubmed: 25605901
J Chem Theory Comput. 2020 Aug 11;16(8):5348-5357
pubmed: 32579371
Proc Natl Acad Sci U S A. 2021 Nov 16;118(46):
pubmed: 34750265
PLoS Comput Biol. 2015 Oct 27;11(10):e1004381
pubmed: 26505480
Biophys J. 2017 Feb 28;112(4):620-629
pubmed: 28256222
Pharm Res. 2000 Nov;17(11):1345-53
pubmed: 11205726
PLoS Biol. 2006 May;4(5):e144
pubmed: 16640460
N Engl J Med. 2001 Apr 5;344(14):1031-7
pubmed: 11287972
Cancer Res. 2009 Mar 15;69(6):2384-92
pubmed: 19276351
Phys Rev Lett. 2013 Dec 6;111(23):230602
pubmed: 24476246
J Chem Theory Comput. 2017 Jul 11;13(7):3372-3377
pubmed: 28582625
Proc Natl Acad Sci U S A. 2016 Mar 15;113(11):2839-44
pubmed: 26929365

Auteurs

Mrinal Shekhar (M)

Center for Development of Therapeutics, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.

Zachary Smith (Z)

Biophysics Program and Institute for Physical Science and Technology, University of Maryland, College Park, MD 20742, USA.

Markus A Seeliger (MA)

Department of Pharmacological Sciences, Stony Brook University, Stony Brook, NY 11794-8651, USA.

Pratyush Tiwary (P)

Department of Chemistry and Biochemistry and Institute for Physical Science and Technology, University of Maryland, College Park, MD 20742, USA.

Articles similaires

T-Lymphocytes, Regulatory Lung Neoplasms Proto-Oncogene Proteins p21(ras) Animals Humans

Pathogenic mitochondrial DNA mutations inhibit melanoma metastasis.

Spencer D Shelton, Sara House, Luiza Martins Nascentes Melo et al.
1.00
DNA, Mitochondrial Humans Melanoma Mutation Neoplasm Metastasis

Prevalence and implications of fragile X premutation screening in Thailand.

Areerat Hnoonual, Sunita Kaewfai, Chanin Limwongse et al.
1.00
Humans Fragile X Mental Retardation Protein Thailand Male Female
Humans Receptors, Antigen, T-Cell Proto-Oncogene Proteins p21(ras) Pancreatic Neoplasms T-Lymphocytes

Classifications MeSH